Free Trial
→ Elon’s Secret Social Security Bombshell (From Banyan Hill Publishing) (Ad)tc pixel

Sartorius Aktiengesellschaft (ETR:SRT) Trading Down 2% - Should You Sell?

Written by MarketBeat
September 25, 2025
Sartorius Aktiengesellschaft logo with Medical background

Key Points

  • Sartorius Aktiengesellschaft's stock fell by 2% during Thursday trading, dropping to a last traded price of €167.40 ($194.65).
  • The company has a market capitalization of $13.01 billion and a high P/E ratio of 84.21, indicating a premium valuation compared to its earnings.
  • Sartorius provides various bioprocess solutions and lab products for both domestic and international markets, showcasing its diverse product portfolio.
  • Five stocks we like better than Sartorius Aktiengesellschaft.

Sartorius Aktiengesellschaft (ETR:SRT - Get Free Report) fell 2% during trading on Thursday . The stock traded as low as €166.80 ($193.95) and last traded at €167.40 ($194.65). 4,509 shares were traded during mid-day trading, The stock had previously closed at €170.80 ($198.60).

Sartorius Aktiengesellschaft Price Performance

The firm has a 50 day moving average price of €160.51 and a 200 day moving average price of €170.37. The company has a quick ratio of 0.36, a current ratio of 2.02 and a debt-to-equity ratio of 169.56. The stock has a market cap of $13.01 billion, a P/E ratio of 84.21, a P/E/G ratio of 2.28 and a beta of 0.93.

About Sartorius Aktiengesellschaft

(Get Free Report)

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Sartorius Aktiengesellschaft Right Now?

Before you consider Sartorius Aktiengesellschaft, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sartorius Aktiengesellschaft wasn't on the list.

While Sartorius Aktiengesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover
The 10 Best AI Stocks to Own in 2025

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.